Department of Polymer Science and Technology, University of Calcutta, 92, A.P.C. Road, Kolkata 700009, India.
Department of Physiology, University of Calcutta, 92, A.P.C. Road, Kolkata 700009, India.
Int J Biol Macromol. 2015 Jan;72:640-8. doi: 10.1016/j.ijbiomac.2014.08.040. Epub 2014 Sep 17.
Chitosan-alginate (CS/ALG) nanoparticles were prepared by formation of an ionotropic pre-gelation of an alginate (ALG) core entrapping insulin, followed by chitosan (CS) polyelectrolyte complexation, for successful oral insulin administration. Mild preparation process without harsh chemicals is aimed at improving insulin bio-efficiency in in vivo model. The nanoparticles showed an average particle size of 100-200 nm in dynamic light scattering (DLS), with almost spherical or sub-spherical shape and ∼ 85% of insulin encapsulation. Again, retention of almost entire amount of encapsulated insulin in simulated gastric buffer followed by its sustained release in simulated intestinal condition proved its pH sensitivity in in vitro release studies. Significant hypoglycemic effects with improved insulin-relative bioavailability (∼ 8.11%) in in vivo model revealed the efficacy of these core-shell nanoparticles of CS/ALG as an oral insulin carrier. No systemic toxicity was found after its peroral treatment, suggesting these core-shell nanoparticles as a promising device for potential oral insulin delivery.
壳聚糖-海藻酸钠(CS/ALG)纳米粒通过形成离子型预凝胶化海藻酸钠(ALG)核心包埋胰岛素,随后壳聚糖(CS)聚电解质复合,成功实现了口服胰岛素给药。温和的制备过程不使用苛刻的化学物质,旨在提高体内模型中胰岛素的生物效率。纳米粒在动态光散射(DLS)中显示出 100-200nm 的平均粒径,具有几乎球形或亚球形形状和约 85%的胰岛素包封率。同样,在模拟胃缓冲液中保留几乎全部包封的胰岛素,然后在模拟肠条件下持续释放,证明了其在体外释放研究中的 pH 敏感性。体内模型中观察到显著的降血糖作用和改善的胰岛素相对生物利用度(约 8.11%),证明了 CS/ALG 这种核壳纳米粒作为口服胰岛素载体的功效。口服治疗后未发现全身毒性,表明这些核壳纳米粒作为潜在口服胰岛素递送的有前途的装置。